Intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment.

Intratumoral heterogeneity, its contribution to therapy resistance and methodological caveats to assessment.

Bibliographic Details
Main Authors:	Mirjam eRenovanz, Ella L Kim
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2014-06-01
Series:	Frontiers in Oncology
Subjects:	cancer stem cells intratumor heterogeneity tumor recurrence intratumor spatiotemporal patterns tumor clones selection
Online Access:	http://journal.frontiersin.org/Journal/10.3389/fonc.2014.00142/full

Similar Items

Dynamic interplay of intratumoral microbiota within the colorectal cancer microenvironment
by: Yuanyuan Wu, et al.
Published: (2024-02-01)

The crosstalk of intratumor bacteria and the tumor
by: Jiating Huang, et al.
Published: (2024-01-01)

Quantitative models for the inference of intratumor heterogeneity
by: Tom van denBosch, et al.
Published: (2022-06-01)

An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma
by: Cong Liu, et al.
Published: (2022-07-01)

Metabolic rearrangements and intratumoral heterogeneity for immune response in hepatocellular carcinoma
by: Fei-Qi Xu, et al.
Published: (2023-01-01)

Epigenetic heterogeneity in cancer
by: Mingzhou Guo, et al.
Published: (2019-10-01)

Intratumoral Heterogeneity in Differentiated Thyroid Tumors: An Intriguing Reappraisal in the Era of Personalized Medicine
by: Antonio Ieni, et al.
Published: (2021-04-01)

Intratumor Heterogeneity Correlates With Reduced Immune Activity and Worse Survival in Melanoma Patients
by: Zhen Lin, et al.
Published: (2020-12-01)

MHC Intratumoral Heterogeneity May Predict Cancer Progression and Response to Immunotherapy
by: Irene Romero, et al.
Published: (2018-01-01)

Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity
by: Felix L. Fennemann, et al.
Published: (2019-04-01)

The loss of neoantigens is an important reason for immune escape in multiple myeloma patients with high intratumor heterogeneity
by: Yue Wang, et al.
Published: (2023-12-01)

Intratumoral Heterogeneity in Lung Cancer
by: Xiaodi Lv, et al.
Published: (2023-05-01)

Intratumor heterogeneity index of breast carcinomas based on DNA methylation profiles
by: Emanuel M. Campoy, et al.
Published: (2019-04-01)

Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach
by: Taichiro Goto, et al.
Published: (2018-06-01)

Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach
by: Pamela Acha, et al.
Published: (2021-02-01)

Genetic dissection of intratumor heterogeneity of PD‐L1 expression in EGFR‐mutated lung adenocarcinoma
by: Kei Kunimasa, et al.
Published: (2023-08-01)

Integrating bulk and single-cell RNA sequencing data reveals the relationship between intratumor microbiome signature and host metabolic heterogeneity in breast cancer
by: Fangyue Chen, et al.
Published: (2023-03-01)

Influence of Intratumor Heterogeneity on the Predictivity of MGMT Gene Promoter Methylation Status in Glioblastoma
by: Giovanni Brigliadori, et al.
Published: (2020-10-01)

Tumor Heterogeneity and Consequences for Bladder Cancer Treatment
by: Etienne Lavallee, et al.
Published: (2021-10-01)

Intratumoral microbiota: implications for cancer onset, progression, and therapy
by: Jinmei Wu, et al.
Published: (2024-01-01)

Circulating Cell-Free DNA Reflects the Clonal Evolution of Breast Cancer Tumors
by: Jouni Kujala, et al.
Published: (2022-03-01)

Intratumoral infection by CMV may change the tumor environment by directly interacting with tumor-associated macrophages to promote cancer immunity
by: Dan A. Erkes, et al.
Published: (2017-08-01)

Recurrence‐free interval 12 months after local treatment of mast cell tumors in dogs using intratumoral injection of tigilanol tiglate
by: Pamela D. Jones, et al.
Published: (2021-01-01)

Research progress of the intratumoral microbiome
by: LI Xinran, LIANG Yiyi, TU Hong
Published: (2023-09-01)

Intratumoral microbiome and gastrointestinal cancers
by: Shengnan Li, et al.
Published: (2022-11-01)

CT-based radiogenomic analysis dissects intratumor heterogeneity and predicts prognosis of colorectal cancer: a multi-institutional retrospective study
by: Min-Er Zhong, et al.
Published: (2022-12-01)

Machine learning developed an intratumor heterogeneity signature for predicting prognosis and immunotherapy benefits in cholangiocarcinoma
by: Xu Chen, et al.
Published: (2024-05-01)

Intratumor Heterogeneity of MYO18A and FBXW7 Variants Impact the Clinical Outcome of Stage III Colorectal Cancer
by: Peng-Chan Lin, et al.
Published: (2020-10-01)

Development of Glioblastoma from Stem Cells to a Full-Fledged Tumor
by: Pavel Vladimirovich NIKITIN, et al.
Published: (2023-05-01)

Predictable regulation of survival by intratumoral microbe-immune crosstalk in patients with lung adenocarcinoma
by: Shuo Shi, et al.
Published: (2024-02-01)

The Role of Intra-Tumoral Heterogeneity and Its Clinical Relevance in Epithelial Ovarian Cancer Recurrence and Metastasis
by: Cai M. Roberts, et al.
Published: (2019-07-01)

New insights from the widening homogeneity perspective to target intratumor heterogeneity
by: Mengying Tong, et al.
Published: (2018-05-01)

Intratumor heterogeneity of prognostic DNA-based molecular markers in adrenocortical carcinoma
by: Anne Jouinot, et al.
Published: (2020-08-01)

Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
by: Luis Alejandro Zúñiga, et al.
Published: (2022-09-01)

Intratumoral heterogeneity for inactivating frameshift mutation of CUX1 and SIRT1 genes in gastric and colorectal cancers
by: Yun Sol Jo, et al.
Published: (2017-11-01)

Progress of Research on Combination of Intratumoral Immune Injection and Radiotherapy for Tumor
by: DAI Juanjuan, et al.
Published: (2023-06-01)

The effect of the intratumoral microbiome on tumor occurrence, progression, prognosis and treatment
by: Feng Gao, et al.
Published: (2022-11-01)

Intratumoral bacteria in uveal melanoma: A case report
by: Katherine Vega Escobar, et al.
Published: (2023-06-01)

Intratumor heterogeneity and clonal evolution revealed in castration-resistant prostate cancer by longitudinal genomic analysis
by: Wenhui Zhang, et al.
Published: (2022-02-01)

Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer
by: Pascale Kündig, et al.
Published: (2018-05-01)